Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 2015, 142979

Ginger and Its Constituents: Role in Prevention and Treatment of Gastrointestinal Cancer

Affiliations
Review

Ginger and Its Constituents: Role in Prevention and Treatment of Gastrointestinal Cancer

Sahdeo Prasad et al. Gastroenterol Res Pract.

Abstract

Gastrointestinal (GI) cancer, a cancer of different organs of the digestive system, is one of the most common cancers around the world. The incidence and death rate of some of these cancers are very high. Although a large variety of chemotherapeutic agents have been introduced since the last few decades to combat GI cancer, most of them are very expensive and have side effects. Therefore, the compounds derived from natural sources, which are considered to be safe and cost effective, are needed. Ginger (Zingiber officinale) is one of the most widely used natural products consumed as a spice and medicine for treating nausea, dysentery, heartburn, flatulence, diarrhea, loss of appetite, infections, cough, and bronchitis. Experimental studies showed that ginger and its active components including 6-gingerol and 6-shogaol exert anticancer activities against GI cancer. The anticancer activity of ginger is attributed to its ability to modulate several signaling molecules like NF-κB, STAT3, MAPK, PI3K, ERK1/2, Akt, TNF-α, COX-2, cyclin D1, cdk, MMP-9, survivin, cIAP-1, XIAP, Bcl-2, caspases, and other cell growth regulatory proteins. In this review, the evidences for the chemopreventive and chemotherapeutic potential of ginger extract and its active components using in vitro, animal models, and patients have been described.

Figures

Figure 1
Figure 1
Different cancer types which are categorized under gastrointestinal cancer.
Figure 2
Figure 2
Ginger, ginger rhizome, and its major active components: 6-gingerol, 6-shogaol, and 6-paradol.
Figure 3
Figure 3
Molecular targets of ginger and its active constituents against gastrointestinal cancer.

Similar articles

See all similar articles

Cited by 29 articles

See all "Cited by" articles

References

    1. Marieb E. N. Essentials of Human Anatomy and Physiology. 8th. New York, NY, USA: Benjamin Cummings; 2005.
    1. Klint Å., Engholm G., Storm H. H., et al. Trends in survival of patients diagnosed with cancer of the digestive organs in the Nordic countries 1964–2003 followed up to the end of 2006. Acta Oncologica. 2010;49(5):578–607. doi: 10.3109/02841861003739330. - DOI - PubMed
    1. Siegel R., Desantis C., Jemal A. Colorectal cancer statistics, 2014. CA Cancer Journal for Clinicians. 2014;64(2):104–117. doi: 10.3322/caac.21220. - DOI - PubMed
    1. Prasad S., Kim J. H., Gupta S. C., Aggarwal B. B. Targeting death receptors for TRAIL by agents designed by mother nature. Trends in Pharmacological Sciences. 2014;35(10):520–536. doi: 10.1016/j.tips.2014.07.004. - DOI - PubMed
    1. Prasad S., Sung B., Aggarwal B. B. Age-associated chronic diseases require age-old medicine: role of chronic inflammation. Preventive Medicine. 2012;54:S29–S37. doi: 10.1016/j.ypmed.2011.11.011. - DOI - PMC - PubMed
Feedback